Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this study is to determine the benefit of the Chalaxie pedagogical evaluation tool in the management of overweight or obese children with intellectual disability.
Chalaxie is a software developped as a pedagogical evaluation tool. It is used in the therapeutic education of overweight and obese children and allow the clinican to explore several skills of the child, such as self-esteem.
Secondary objectives
Conduct of research After receiving written consent from the study participant and parental authority, the patients will have two visits with the pediatrician during which they will use the Chalaxie pedagogical evaluation tool. At the first visit, they will use the self-esteem assessment module. At the second visit (i.e. final visit), which should take place between 3 weeks and 2 months after the first visit, they will use a module of their choice.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Overweight or obese minors with intellectual disability | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Use of the Chalaxie pedagogical evaluation tool | Procedure | Use of the Chalaxie pedagogical evaluation tool during two visits |
|
| Measure | Description | Time Frame |
|---|---|---|
| Self-report patient perception questionnaire | The benefit of the Chalaxie pedagogical evaluation tool will be measured with the patient perception questionnaire completed at the final visit. It consists of seven single choice questions and one open question. | through study completion, an average of 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of the visit | Duration will be measured from the moment the written consent is obtained until the end of the visit | on enrollment day only |
| Duration of the use of the self-esteem assessment module |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| fatiha Guemazi-Kheffi, MD | Groupe Hospitalier de la Région de Mulhouse et Sud-Alsace | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Emile Muller (GHRMSA) | Mulhouse | 68100 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Duration will be measured from the moment the investigator clicks on the module until the completion of the last question.
| on enrollment day only |
| Clinician perception questionnaire | Clinician perception questionnaire consists of 12 single choice questions. | Through study completion, on enrollment day to the final visit, an average of 2 months |
| Self-esteem | Self-esteem will be evaluated with the self-esteem assessment module. It consists of 6 questions with a visual scale of 6 emoticons. It also includes a 4-modality question assessing overall self-esteem that is completed by the patient and pediatrician respectively. | on enrollment day only |
| ID | Term |
|---|---|
| D063766 | Pediatric Obesity |
| D008607 | Intellectual Disability |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided